Mannatech Reports Second Quarter 2012 Financial Results
COPPELL, Texas--(BUSINESS WIRE)-- Mannatech, Incorporated (NASDAQ: MTEX ), a leading developer and provider of nutritional supplements and skin care products based on Real Food Technology® solutions, today reported a net loss of $2.4 million, or $0.93 per diluted share, for the second quarter ending June 30, 2012, compared to a net loss of $5.2 million, or $1.98 per diluted share, for the second quarter of 2011.
Net sales for the second quarter of 2012 were $43.6 million, a decrease of 15.1%, compared to $51.3 million in the second quarter of 2011. Net sales for the United States and Canada declined 11.7% to $22.6 million, compared to $25.6 million in the second quarter of 2011. International net sales of $21.0 million decreased 18.6%, compared to $25.8 million in the second quarter of 2011.
Recruiting increased 37.5% as compared to the second quarter of 2011. New independent associates and members for the second quarter of 2012 were 27,570 compared to 20,048 in 2011. Total active independent associates and members eligible to purchase our products based on a 12-month trailing period were approximately 378,000 as of June 30, 2012, compared to 385,000 as of June 30, 2011.
Dr. Robert Sinnott, CEO and Chief Science Officer, commented, The acceptance in the field of our newest product, NutriVerus", and our 4Free Discount Program initiative in North America has resulted in a strong increase in recruiting during the second quarter. We believe the energy of our field in other markets is similarly positioned as NutriVerus" is expected to launch in those markets over the next few months.
Mannatech (MTEX) will hold a conference call and webcast to discuss this announcement with investors on Thursday, August 9, 2012 at 9:00 a.m. Central Daylight Time/10:00 a.m. Eastern Daylight Time. Investors may listen to the call by accessing Mannatechs website at Mannatech.com. For those unable to listen to the live broadcast, a replay will be available shortly after the call. The toll-free replay number is 855-859-2056 (International: 404-537-3406); the Conference ID to access the call is 14133242.
Individuals interested in Mannatechs products or in exploring its business opportunity can learn more at Mannatech.com.
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of social entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatechs proprietary products are available through independent sales associates around the globe including the United States, Canada, South Africa, the Republic of Namibia, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea and Mexico. For more information, visit Mannatech.com.
Please Note: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as anticipate, believe, will, intend or other similar words or the negative of such terminology. Similarly, descriptions of Mannatechs objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatechs inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
|MANNATECH, INCORPORATED AND SUBSIDIARIES|
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(in thousands, except share and per share amounts)
|Cash and cash equivalents||$||12,103||$||18,057|
|Accounts receivable, net of allowance of $23 and $22 in 2012 and 2011, respectively||187||304|
|Income tax receivable||892||888|
|Prepaid expenses and other current assets||2,179||2,497|
|Deferred tax assets||978||936|
|Total current assets||36,036||41,731|
|Property and equipment, net||6,374||9,566|
|Construction in progress||3|
|Long-term restricted cash||3,459||3,386|
|Long-term deferred tax assets||846||772|
|LIABILITIES AND SHAREHOLDERS EQUITY|
|Current portion of capital leases||$||714||$||852|
|Commissions and incentives payable||5,813||8,567|
|Current deferred tax liability||209||185|
|Total current liabilities||25,404||29,876|
|Capital leases, excluding current portion||1,112||1,358|
|Long-term deferred tax liabilities||1||1|
|Other long-term liabilities||5,767||5,382|
|Commitments and contingencies|
|Preferred stock, $0.01 par value, 1,000,000 shares authorized, no|
|shares issued or outstanding|
|Common stock, $0.0001 par value, 99,000,000 shares authorized,|
|2,768,972 shares issued and 2,647,735 shares outstanding as of|
|June 30, 2012 and 2,769,756 shares issued and 2,648,518 shares|
|outstanding as of December 31, 2011|
|Additional paid-in capital||42,529||42,408|
|Accumulated other comprehensive loss||(788||)||(427||)|
|Less treasury stock, at cost, 121,237 shares in 2012 and 2011||(14,796||)||(14,796||)|
|Total shareholders equity||17,558||21,653|
|Total liabilities and shareholders equity||$||49,842||$||58,270|
|MANNATECH, INCORPORATED AND SUBSIDIARIES|
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(in thousands, except per share information)
Three months ended
Six months ended
|Cost of sales||6,888||7,543||13,283||14,757|
|Commissions and incentives||18,637||22,896||37,622||44,603|
|Selling and administrative||11,793||14,811||23,277||30,829|
|Depreciation and amortization||921||2,687||3,379||5,488|
|Other operating costs||6,778||7,746||14,014||15,812|
|Total operating expenses||19,492||25,244||40,670||52,129|
|Loss from operations||(1,406||)||(4,321||)||(3,462||)||(9,227||)|
|Interest income (expense)||21||21||(32||)||1|
|Other income (expense), net||(805||)||196||87||463|
|Loss before income taxes||(2,190||)||(4,104||)||(3,407||)||(8,763||)|
|Provision for income taxes||(265||)||(1,146||)||(448||)||(1,265||)|
|Net loss per share:|
|Weighted-average common shares outstanding:|
The approximate number of new and continuing associates who purchased our packs or products during the twelve months ended June 30, 2012 and 2011, plus member accounts eligible to purchase products were as follows:
Donna Giordano, 972-471-6512
Manager, Executive Office Administration
Source: Mannatech, IncorporatedCopyright Business Wire 2012